de-Landazuri, Inaki-Ortiz; Oliver-Caldes, Aina; Espanol-Rego, Marta; Agullo, Cristina; Contreras, María-Teresa; Zabaleta, Aintzane; Puig, Noemi; Cabanas, Valentin; González-Calle, Verónica; Zugasti, Ines; Inoges, Susana; Otero, Paula-Rodríguez; Martín-Antonio, Beatriz; Reguera, Juan-Luis; de-Cerio, Ascensión-López-Diaz; Arostegui, Juan-Ignacio; Uribe-Herranz, Mireia; Benitez-Ribas, Daniel; Rodríguez-Lobato, Luis-Gerardo; González, Europa-Azucena; Tovar, Natalia; Charry, Paola; Navarro, Sergio; Rosinol, Laura; Treboles, Karen; Mora, Genesis; Yague, Jordi; Moraleda-Jiménez, José-María; Urbano-Ispizua, Álvaro; Mateos, María-Victoria; Pascal, Mariona; Paiva, Bruno; Juan, Manel; de-Larrea, Carlos-Fernández
(WILEY, 2024-10)
Chimeric antigen receptor (CAR) T-cell therapies have increased the patients with relapsed/refractory multiple myeloma (RRMM) in whom standard electrophoretic techniques fail to detect the M-protein. Quantitative ...